Recently, the Hubei Provincial Department of Economy and Information Technology officially announced the list of candidates for the “2025 Hubei Provincial Innovative Product Application Demonstration Recommended Catalog”. The “Breast Lesion Rotational Biopsy Equipment (Model: BBT-SCB180)” independently developed by Wuhan Half the Sky Medical Technology Development Co., Ltd. was successfully selected for its outstanding technological innovation and clinical value, demonstrating Wuhan Half the Sky’s R&D strength and core competitiveness in the field of high-end medical devices.
This selection is based on the “Hubei Province Innovative Product Application Demonstration Implementation Plan” jointly issued by the Provincial Department of Economy and Information Technology and ten other departments, and in accordance with the requirements of the “Notice on Carrying out the Compilation of the 2025 Hubei Province Innovative Product Application Demonstration Recommended Catalog”, through voluntary declaration by the unit, recommendation by the municipal and state economic and information bureaus, review and evaluation by industry experts, and approval by a joint meeting.
Selected products must conform to the development direction of key industries and reach high standards in terms of core technology, independent intellectual property rights, market potential, etc. It is an authoritative recognition of corporate technological innovation and product competitiveness.
Breast lesion rotational biopsy equipment (BBT-SCB180) is a minimally invasive diagnosis and treatment system for breast lesions independently developed by Wuhan Bantian. It covers the entire cycle of breast disease diagnosis and treatment and can be used for biopsy sampling of suspicious breast lesions and minimally invasive resection of benign breast lesions.
Its working principle focuses on “precise minimally invasive”: under the real-time guidance and dynamic observation of B-ultrasound, the lesion tissue is firmly fixed through the negative pressure suction system, and the precise and complete resection of the lesion is completed with a high-speed rotating cutter. With its significant clinical advantages of firm suction, fast cutting, and complete surgery, this device can effectively reduce the trauma to patients caused by traditional surgery, greatly improve the efficiency of diagnosis and treatment, and provide a better minimally invasive solution for the diagnosis and treatment of breast diseases.
This successful selection into the provincial recommended catalog of innovative products is a high recognition of Wuhan Half the Sky’s continued efforts in the field of minimally invasive medical devices and its persistence in innovation. From laboratory to clinical application, from technological breakthroughs to industrial upgrading, Wuhan Half the Sky will continue to adhere to the mission of “healthy half the sky, benefiting all mankind”, continue to polish more specialties, better quality medical device products and minimally invasive diagnosis and treatment solutions, and contribute more “Half the Sky” power to achieve independent control of China’s medical health!
